NWBO (OTC)
NORTHWEST BIOTHRPUTCS INC
$0.190200
-0.001600 (-0.83%)
Prev close: $0.191800
Company Information
- Exchange
- OTC Link
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Linda F. Powers
- Asset Type
- otc
- Website
- —
Fundamentals
- Market Cap
- $315.50M
- Employees
- 25
- P/E (TTM)
- -6.27
- P/B (TTM)
- -6.11
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $1.50M |
| Benefits Costs and Expenses | $120.37M |
| Costs And Expenses | $149.80M |
| Operating Expenses | $55.00M |
| Depreciation and Amortization | $2.40M |
| Research and Development | $25.29M |
| Other Operating Expenses | $28.21M |
| Operating Income/Loss | -$53.50M |
| Income/Loss From Continuing Operations After Tax | -$160.87M |
| Income/Loss From Continuing Operations Before Tax | -$118.87M |
| Net Income/Loss | -$160.91M |
| Net Income/Loss Attributable To Noncontrolling Interest | -$117.02M |
| Net Income/Loss Attributable To Parent | -$43.89M |
| Net Income/Loss Available To Common Stockholders, Basic | -$45.27M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $1.38M |
| Preferred Stock Dividends And Other Adjustments | $1.38M |
| Basic Earnings Per Share | -$0.03 |
| Diluted Earnings Per Share | -$0.03 |
| Basic Average Shares | 3,043,005,867 |
| Diluted Average Shares | 3,043,005,867 |
| Assets | $80.05M |
| Current Assets | $6.20M |
| Noncurrent Assets | $73.85M |
| Fixed Assets | $16.77M |
| Intangible Assets | $52.05M |
| Other Non-current Assets | $5.03M |
| Liabilities | $118.11M |
| Current Liabilities | $82.97M |
| Noncurrent Liabilities | $35.14M |
| Long-term Debt | $59.43M |
| Equity | -$50.54M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | -$50.54M |
| Liabilities And Equity | $80.05M |
| Net Cash Flow From Operating Activities | -$47.85M |
| Net Cash Flow From Operating Activities, Continuing | -$47.85M |
| Net Cash Flow From Investing Activities | -$1.85M |
| Net Cash Flow From Investing Activities, Continuing | -$1.85M |
| Net Cash Flow From Financing Activities | $46.80M |
| Net Cash Flow From Financing Activities, Continuing | $46.80M |
| Net Cash Flow | -$2.90M |
| Net Cash Flow, Continuing | -$2.90M |
| Comprehensive Income/Loss | -$47.10M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$47.10M |
| Other Comprehensive Income/Loss | $71.60M |